Effect of depot medroxyprogesterone acetate on bone mineral density in adolescent women

Chinese Medical Journal

Volumn 126, Issue 21, 2013, Pages 4043-4047

  Zhang, Mei Hua ^a   Zhang, Wei ^a   Zhang, Ai Dong ^a   Yang, Yan ^a   Gai, Ling ^a  

^a Shandong Provincial Institute of Science and Technology for Family Planning   (China)

Author keywords

Adolescents; Bone mineral density; Contraception; Depot medroxyprogesterone acetate

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADOLESCENT; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; LUMBAR SPINE; OSTEOPOROSIS;

ADOLESCENT; BONE DENSITY; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; MEDROXYPROGESTERONE ACETATE;

EID: 84887083724     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20130885     Document Type: Article

References (23)

1. Harel Z, Johnson CC, Gold MA, Cromer B, Peterson E, Burkman R, et al. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections. Contraception 2010; 81: 281-291
2. Meier C, Brauchli YB, Jick SS, Kraenzlin ME, Meier CR. Use of depot medroxyprogesterone acetate and fracture risk. J Clin Endocrinol Metab 2010; 95: 4909-4916
3. Cromer BA, Scholes D, Berenson A, Cundy T, Clark MK, Kaunitz AM, et al. Depot medroxyprogesterone acetate and bone mineral density in adolescents-the black box warning: a position paper of the society for adolescent medicine. J Adolesc Health 2006; 39: 296-301
4. Dempster DW, Bolognese MA. The evolution of a once-a-month oral therapy for postmenopausal osteporosis. J Clin Densitom 2006; 9: 58-65
5. Nappi C, Bifulco G, Tommaselli GA, Gargano V, Di Carlo C. Hormonal contraception and bone metabolism: a systematic review. Contraception 2012; 86: 606-621
6. Cundy T, Ames R, Horne A, Clearwater J, Roberts H, Gamble G, et al. A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate. J Clin Endocrinol Metab 2003; 88: 78-81
7. Miller KK, Kilbanski A. Amenorrheic bone loss. J Clin Endocrinol Metab 1999; 84: 1775-1783
8. Clart MK, Sower M, Levy BT, Tenhundfeld P. Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception. Fertil Steril 2001; 75: 871-877
9. Scholes D, LaCroix AZ, Ichikawa L, Barlow WE, Ott SM. The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women. Contraception 2004; 69: 99-104
10. Pitts SAB, Feldman HA, Dorale A, Gordon CM. Bone mineral density, fracture, and Vitamin D in adolescents and young women using depot medroxyprogesterone acetate. J Pedia Adoles Gynec 2012; 25: 23-26
11. Beksinska ME, Kleinschmidt I, Smit JA, Farley TM, Rees HV. Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception. Contraception 2009; 80: 128-132
12. Curtis KM, Martins SL. Progestogen-only contraception and bone mineral density: a systematic review. Contraception 2006; 73: 470-487
13. Gai L, Zhang JL, Zhang HZ, Gai P, Zhou L, Liu YH. The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age. Contraception 2011; 83: 218-222
14. Cromer BA, Stager M, Bonny A, Lazebnik R, Rome E, Ziegler J, et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health 2004; 35: 434-441
15. Beksinska ME, Kleinschmidt I, Smit JA, Farley TM. Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate. Contraception 2009; 79: 345-349
16. Tharnprisam W, Taneepanichskul S. Bone mineral density in adolescent and young Thai girls receiving oral contraceptives compared with depot medroxyprogesterone acetate: a cross-sectional study in young Thai women. Contraception 2002; 66: 101-103
17. Bahamondes L, Perotti M, Castro S, Faundes D, Petta C, Bedone A. Forearm bone density in users of Depot-Provera as a contraceptive method. Fertil Steril 1999; 71: 849-852
18. Tang OS, Tang G, Yip PS, Li B. Further evaluation on long-term depot-medroxyprogesterone acetate use and bone mineral density: a longitudinal cohort study. Contraception 2000; 62: 161-164
19. Berenson AB, Breitkopf CR, Grady JJ, Rickert VI, Thomas A. Effects of hormonal contraception on bone mineral density after 24 months of use. Obstet Gynecol 2004; 103: 899-906
20. Clark MK, Sowers MF, Nichols S, Levy B. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate. Fertil Steril 2004; 82: 1580-1586
21. Kaunitz AM, Miller PD, Rice VM, Ross D, McClung MR. Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation. Contraception 2006; 74: 90-99
22. Berenson AB, Rahman M, Breitkopf CR, Bi LX. Effects of depot medroxyprogesterone acetate and 20 ug oral contraceptives on bone mineral density. Obstet Gynecol 2008; 112: 788-799
23. Cromer BA, Bonny AE, Stager M, Lazebnik R, Rome E, Ziegler J, et al. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24 month prospective study. Fertil Steril 2008; 90: 2060-2067